Loading
Latest filing published 22 May 2025 for NervGen Pharma Corp..
No signal scores available.
Daniel Mikol appears in our data through filings on NervGen Pharma Corp. shares, published by SEDI. Over a trading history stretching from 5 May 2021 to 20 May 2025, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 22 May 2025, reports a transaction in NervGen Pharma Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations